A Case of Daratumumab-Induced Significant Decrease in Donor-Specific HLA Antibodies and Remission Induction Before Haploidentical Stem Cell Transplantation in a Refractory B-ALL Patient

OBJECTIVE: To explore the method of eliminating donor-specific anti-HLA antibodies (DSA) in haploidentical stem cell transplantation (haplo-SCT). METHODS: We present a refractory B-cell acute lymphoblastic leukemia (ALL) patient who had strongly positive DSA, but had no human leukocyte antigen–match...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Zhu, Haibo, Sui, Tao, Zhao, Xingli, Deng, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597015/
https://www.ncbi.nlm.nih.gov/pubmed/36278404
http://dx.doi.org/10.1177/09636897221132502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597015/
https://www.ncbi.nlm.nih.gov/pubmed/36278404
http://dx.doi.org/10.1177/09636897221132502

Ejemplares similares